Table 2.
Characteristics of cryptogenic stroke patients with and without cancer
| Cryptogenic stroke patient characteristics | With cancer (n = 68) | Without cancer (n = 113) | P Value |
|---|---|---|---|
| Age, years | 67 (60–75) | 68 (57–74) | 0.76 |
| Women, % | 46 | 39 | 0.38 |
| Body mass index, kg/m2 | 19.7 (16.9–22.4) | 22.7 (20.3–25.2) | <0.001 |
| Atherosclerotic risk factors, n | 1 (0–2) | 2 (1–3) | <0.001 |
| Hypertension, % | 35 | 58 | 0.005 |
| Hyperlipidemia, % | 37 | 57 | 0.001 |
| Diabetes mellitus, % | 19 | 31 | 0.08 |
| Current smoking, % | 15 | 20 | 0.34 |
| Past stroke, % | 18 | 22 | 0.47 |
| Laboratory findings | |||
| White blood cells, /μL | 7,565 (4,985–10,738) | 6,750 (5,110–8,620) | 0.36 |
| Total lymphocytes, /μL | 904 (585–1270) | 1,492 (1,068–1,892) | <0.001 |
| Hemoglobin, g/dL | 10.6 (8.4–12.1) | 12.9 (11.4–14.7) | <0.001 |
| Platelets × 104/μL | 14.4 (8.3 – 22.1) | 21.5 (17.0–25.7) | <0.001 |
| Total cholesterol, mg/dL | 169 (135–205) | 192 (156–215) | 0.02 |
| Albumin, g/dL | 3.2 (2.6–3.7) | 4.0 (3.6–4.2) | <0.001 |
| D‐dimer, μg/mL | 5.1 (2.6–16.2) | 0.5 (0.3–1.0) | <0.001 |
| hsCRP, mg/dL | 1.33 (0.35‐6.80) | 0.14 (0.04‐0.34) | <0.001 |
| CONUT score | 5 (3–8) | 1 (0–3) | <0.001 |
| Imaging findings | |||
| Multiple vascular lesions, % | 71 | 16 | <0.001 |
CONUT, controlling nutritional status; hsCRP, high sensitivity C‐reactive protein.